British Journal of Cancer - Table of Contents alert Volume 112 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 112, Issue 5 (777-956) Published online 3 March 2015 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe   Advertisement PROSTATE CANCER UK SUMMIT 2015 - Saturday 18 April Rethinking the treatment pathway Explore the latest data for interventions in the advanced disease setting and discuss how practice could evolve and improve patient outcomes. The meeting is sponsored by Janssen. February 2015/ PHGB/MEDed/0215/0019. More information and registration here   Minireview Top MicroRNA in radiotherapy: miRage or miRador? E Korpela, D Vesprini and S K Liu Br J Cancer 2015 112: 777-782; advance online publication, January 22, 2015; 10.1038/bjc.2015.6 Abstract | Full Text Clinical Studies Top Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study B Ghanim, T Klikovits, M A Hoda, G Lang, I Szirtes, U Setinek, A Rozsas, F Renyi-Vamos, V Laszlo, M Grusch, M Filipits, A Scheed, M Jakopovic, M Samarzija, L Brcic, D Stancic–Rokotov, I Kern, A Rozman, G Dekan, W Klepetko, W Berger, T Glasz, B Dome and B Hegedus Br J Cancer 2015 112: 783-792; advance online publication, January 29, 2015; 10.1038/bjc.2015.9 Abstract | Full Text Just how accurate are the major risk stratification systems for early-stage endometrial cancer? S Bendifallah, G Canlorbe, P Collinet, E Arsène, F Huguet, C Coutant, D Hudry, O Graesslin, E Raimond, C Touboul, E Daraï and M Ballester Br J Cancer 2015 112: 793-801; advance online publication, February 12, 2015; 10.1038/bjc.2015.35 Abstract | Full Text A urine-based methylation signature for risk stratification within low-risk prostate cancer T A Jatkoe, R J Karnes, S J Freedland, Y Wang, A Le and J Baden Br J Cancer 2015 112: 802-808; advance online publication, February 19, 2015; 10.1038/bjc.2015.7 Abstract | Full Text Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase D Di Gioia, P Stieber, G P Schmidt, D Nagel, V Heinemann and A Baur-Melnyk Br J Cancer 2015 112: 809-818; advance online publication, February 3, 2015; 10.1038/bjc.2015.8 Abstract | Full Text A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer T Sakiyama, J Tsurutani, T Iwasa, H Kawakami, Y Nonagase, T Yoshida, K Tanaka, Y Fujisaka, T Kurata, Y Komoike, K Nishio and K Nakagawa Br J Cancer 2015 112: 819-824; advance online publication, February 5, 2015; 10.1038/bjc.2015.10 Abstract | Full Text Translational Therapeutics Top Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study O K Glass, B A Inman, G Broadwater, K S Courneya, J R Mackey, S Goruk, E R Nelson, J Jasper, C J Field, J R Bain, M Muehlbauer, R D Stevens, M D Hirschey and L W Jones Br J Cancer 2015 112: 825-831; advance online publication, January 13, 2015; 10.1038/bjc.2014.662 Abstract | Full Text Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy Q Tan, A M Joshua, J K Saggar, M Yu, M Wang, N Kanga, J Y Zhang, X Chen, B G Wouters and I F Tannock Br J Cancer 2015 112: 832-840; advance online publication, February 3, 2015; 10.1038/bjc.2015.17 Abstract | Full Text mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma T Scheller, C Hellerbrand, C Moser, K Schmidt, A Kroemer, S M Brunner, H J Schlitt, E K Geissler and S A Lang Br J Cancer 2015 112: 841-850; advance online publication, February 17, 2015; 10.1038/bjc.2014.638 Abstract | Full Text Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival R Kwakman, E M V de Cuba, J P de Winter, I H J T de Hingh, P M Delis-van Diemen, M Tijssen, M A Rooimans, O Krijgsman, B Carvalho, G J Peters, H J Bonjer, G A Meijer and E A te Velde Br J Cancer 2015 112: 851-856; advance online publication, February 10, 2015; 10.1038/bjc.2015.18 Abstract | Full Text OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy W A Teft, S Welch, J Lenehan, J Parfitt, Y-H Choi, E Winquist and R B Kim Br J Cancer 2015 112: 857-865; advance online publication, January 22, 2015; 10.1038/bjc.2015.5 Abstract | Full Text Molecular Diagnostics Top Downregulation of MTSS1 expression is an independent prognosticator in squamous cell carcinoma of the lung G Kayser, A Csanadi, S Kakanou, A Prasse, A Kassem, E Stickeler, B Passlick and A zur Hausen Br J Cancer 2015 112: 866-873; advance online publication, January 27, 2015; 10.1038/bjc.2015.2 Abstract | Full Text High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients M Wang, X Zhu, Z Sha, N Li, D Li and L Chen Br J Cancer 2015 112: 874-882; advance online publication, February 10, 2015; 10.1038/bjc.2015.3 Abstract | Full Text MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53 R F H Walter, F D Mairinger, S Ting, C Vollbrecht, T Mairinger, D Theegarten, D C Christoph, K W Schmid and J Wohlschlaeger Br J Cancer 2015 112: 883-890; advance online publication, February 10, 2015; 10.1038/bjc.2015.27 Abstract | Full Text MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways I Fukumoto, T Hanazawa, T Kinoshita, N Kikkawa, K Koshizuka, Y Goto, R Nishikawa, T Chiyomaru, H Enokida, M Nakagawa, Y Okamoto and N Seki Br J Cancer 2015 112: 891-900; advance online publication, February 10, 2015; 10.1038/bjc.2015.19 Abstract | Full Text Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response M M Al-kaabi, A T Alshareeda, D A Jerjees, A A Muftah, A R Green, N H Alsubhi, C C Nolan, S Chan, E Cornford, S Madhusudan, I O Ellis and E A Rakha Br J Cancer 2015 112: 901-911; advance online publication, February 17, 2015; 10.1038/bjc.2014.576 Abstract | Full Text Epidemiology Top Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models E Laas, P Mallon, M Delomenie, V Gardeux, J-Y Pierga, P Cottu, F Lerebours, D Stevens, R Rouzier and F Reyal Br J Cancer 2015 112: 912-917; advance online publication, January 15, 2015; 10.1038/bjc.2014.641 Abstract | Full Text Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976–2009 I Parvinen, S Heinävaara, A Anttila, H Helenius, P Klemi and L Pylkkänen Br J Cancer 2015 112: 918-924; advance online publication, February 17, 2015; 10.1038/bjc.2014.642 Abstract | Full Text Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2) H P Yang, L S Cook, E Weiderpass, H-O Adami, K E Anderson, H Cai, J R Cerhan, T V Clendenen, A S Felix, C M Friedenreich, M Garcia-Closas, M T Goodman, X Liang, J Lissowska, L Lu, A M Magliocco, S E McCann, K B Moysich, S H Olson, S Petruzella, M C Pike, S Polidoro, F Ricceri, H A Risch, C Sacerdote, V W Setiawan, X O Shu, A B Spurdle, B Trabert, P M Webb, N Wentzensen, Y-B Xiang, Y Xu, H Yu, A Zeleniuch-Jacquotte and L A Brinton Br J Cancer 2015 112: 925-933; advance online publication, February 17, 2015; 10.1038/bjc.2015.24 Abstract | Full Text Television watching and risk of colorectal adenoma Y Cao, N N Keum, A T Chan, C S Fuchs, K Wu and E L Giovannucci Br J Cancer 2015 112: 934-942; advance online publication, January 15, 2015; 10.1038/bjc.2014.655 Abstract | Full Text Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960 A S Ahmad, N Ormiston-Smith and P D Sasieni Br J Cancer 2015 112: 943-947; advance online publication, February 3, 2015; 10.1038/bjc.2014.606 Abstract | Full Text Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data P S Hall, P Hamilton, C T Hulme, D M Meads, H Jones, A Newsham, J Marti, A F Smith, H Mason, G Velikova, L Ashley and P Wright Br J Cancer 2015 112: 948-956; advance online publication, January 20, 2015; 10.1038/bjc.2014.644 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.